Dog Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2023

The global dog vaccine market size is anticipated to reach USD 2.6 billion by 2030 and display a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights:

Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.4% in 2022, as they help prevent disease and provide long-term immunity
Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 6.9% over the forecast period due to the high prevalence of this disease and its zoonotic potential
Based on route of administration, the injectable segment accounted for the largest revenue share of 76.1% in 2022, owing to their convenience and ability to administer accurate dosage amounts
Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2022 owing to their convenience
Based on component, the combined vaccines segment accounted for the largest market share of 65.5%. It is expected to grow at the fastest CAGR of 6.2% over the forecast period due to its ability to protect against more than one disease
North America dominated with a share of 38.8% in 2022, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 7.0% over the forecast period due to untapped opportunities in the emerging economies of China and India

Product Code: GVR-4-68040-156-3

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Vaccine type
- 1.1.2. Disease type
- 1.1.3. Route of administration
- 1.1.4. Duration of immunity
- 1.1.5. Component
- 1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Vaccine type outlook
- 2.2.2. Disease type outlook
- 2.2.3. Route of administration outlook
- 2.2.4. Duration of immunity outlook
- 2.2.5. Component outlook
- 2.2.6. Regional outlook
2.3. Competitive Insights

Chapter 3. Dog Vaccine Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Dog Vaccine Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Dog Vaccine: Vaccine Type Estimates & Trend Analysis

4.1. Dog Vaccine Market: Key Takeaways
4.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Modified/Attenuated Live
- 4.3.1. Modified/ attenuated live market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Inactivated (Killed)
- 4.4.1. Inactivated (Killed) market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Others
- 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Dog Vaccine: Disease Type Estimates & Trend Analysis

5.1. Dog Vaccine Market: Key Takeaways
5.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Canine Distemper
- 5.3.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
- 5.4.1. Canine infectious respiratory disease complex (CIRDC) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Canine Parvovirosis/ Parvovirus Disease
- 5.5.1. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Canine Leptospirosis
- 5.6.1. Canine leptospirosis market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Canine Lyme Disease
- 5.7.1. Canine lyme disease market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Infectious Canine Hepatitis
- 5.8.1. Infectious canine hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Canine Rabies
- 5.9.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Other Diseases
- 5.10.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Dog Vaccine: Route of Administration Estimates & Trend Analysis

6.1. Dog Vaccine Market: Key Takeaways
6.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Injectable
- 6.3.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intranasal
- 6.4.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Oral
- 6.5.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Dog Vaccine: Duration of Immunity Estimates & Trend Analysis

7.1. Dog Vaccine Market: Key Takeaways
7.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
7.3. 1 Year
- 7.3.1. 1-year market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. 3 Year
- 7.4.1. 3-year market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
- 7.5.1. others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Dog Vaccine: Component Estimates & Trend Analysis

8.1. Dog Vaccine Market: Key Takeaways
8.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Combined Vaccines
- 8.3.1. Combined vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Mono Vaccines
- 8.4.1. Mono vaccines market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Dog Vaccine Market: Regional Estimates & Trend Analysis

9.1. Regional Outlook
9.2. Dog Vaccine Market by Region: Key Takeaways
9.3. North America
- 9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.3.2. U.S.
  - 9.3.2.1. Key country dynamics
  - 9.3.2.2. Regulatory framework/reimbursement structure
  - 9.3.2.3. Competitive scenario
  - 9.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.3.3. Canada
  - 9.3.3.1. Key country dynamics
  - 9.3.3.2. Regulatory framework/reimbursement structure
  - 9.3.3.3. Competitive scenario
  - 9.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.4. Europe
- 9.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.2. UK
  - 9.4.2.1. Key country dynamics
  - 9.4.2.2. Regulatory framework/reimbursement structure
  - 9.4.2.3. Competitive scenario
  - 9.4.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.3. Germany
  - 9.4.3.1. Key country dynamics
  - 9.4.3.2. Regulatory framework/reimbursement structure
  - 9.4.3.3. Competitive scenario
  - 9.4.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.4. France
  - 9.4.4.1. Key country dynamics
  - 9.4.4.2. Regulatory framework/reimbursement structure
  - 9.4.4.3. Competitive scenario
  - 9.4.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.5. Italy
  - 9.4.5.1. Key country dynamics
  - 9.4.5.2. Regulatory framework/reimbursement structure
  - 9.4.5.3. Competitive scenario
  - 9.4.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.6. Spain
  - 9.4.6.1. Key country dynamics
  - 9.4.6.2. Regulatory framework/reimbursement structure
  - 9.4.6.3. Competitive scenario
  - 9.4.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.7. Denmark
  - 9.4.7.1. Key country dynamics
  - 9.4.7.2. Regulatory framework/reimbursement structure
  - 9.4.7.3. Competitive scenario
  - 9.4.7.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.8. Sweden
  - 9.4.8.1. Key country dynamics
  - 9.4.8.2. Regulatory framework/reimbursement structure
  - 9.4.8.3. Competitive scenario
  - 9.4.8.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.4.9. Norway
  - 9.4.9.1. Key country dynamics
  - 9.4.9.2. Regulatory framework/reimbursement structure
  - 9.4.9.3. Competitive scenario
  - 9.4.9.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.5. Asia Pacific
- 9.5.1. Japan
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.5.2. China
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.5.3. India
  - 9.5.3.1. Key country dynamics
  - 9.5.3.2. Regulatory framework/reimbursement structure
  - 9.5.3.3. Competitive scenario
  - 9.5.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.5.4. Australia
  - 9.5.4.1. Key country dynamics
  - 9.5.4.2. Regulatory framework/reimbursement structure
  - 9.5.4.3. Competitive scenario
  - 9.5.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.5.5. Thailand
  - 9.5.5.1. Key country dynamics
  - 9.5.5.2. Regulatory framework/reimbursement structure
  - 9.5.5.3. Competitive scenario
  - 9.5.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.5.6. South Korea
  - 9.5.6.1. Key country dynamics
  - 9.5.6.2. Regulatory framework/reimbursement structure
  - 9.5.6.3. Competitive scenario
  - 9.5.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.6. Latin America
- 9.6.1. Brazil
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.6.2. Mexico
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.6.3. Argentina
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Regulatory framework/reimbursement structure
  - 9.6.3.3. Competitive scenario
  - 9.6.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
9.7. MEA
- 9.7.1. South Africa
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.7.2. Saudi Arabia
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.7.3. UAE
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 9.7.4. Kuwait
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
- 10.2.1. Bioveta, a.s.
  - 10.2.1.1. Company overview
  - 10.2.1.2. Financial performance
  - 10.2.1.3. Product benchmarking
  - 10.2.1.4. Strategic initiatives
- 10.2.2. HESTER BIOSCIENCES LIMITED
  - 10.2.2.1. Company overview
  - 10.2.2.2. Financial performance
  - 10.2.2.3. Product benchmarking
  - 10.2.2.4. Strategic initiatives
- 10.2.3. Boehringer Ingelheim International GmbH
  - 10.2.3.1. Company overview
  - 10.2.3.2. Financial performance
  - 10.2.3.3. Product benchmarking
  - 10.2.3.4. Strategic initiatives
- 10.2.4. Brilliant Bio Pharma
  - 10.2.4.1. Company overview
  - 10.2.4.2. Financial performance
  - 10.2.4.3. Product benchmarking
  - 10.2.4.4. Strategic initiatives
- 10.2.5. Heska Corporation
  - 10.2.5.1. Company overview
  - 10.2.5.2. Financial performance
  - 10.2.5.3. Product benchmarking
  - 10.2.5.4. Strategic initiatives
- 10.2.6. Merck & Co., Inc.
  - 10.2.6.1. Company overview
  - 10.2.6.2. Financial performance
  - 10.2.6.3. Product benchmarking
  - 10.2.6.4. Strategic initiatives
- 10.2.7. Virbac
  - 10.2.7.1. Company overview
  - 10.2.7.2. Financial performance
  - 10.2.7.3. Product benchmarking
  - 10.2.7.4. Strategic initiatives
- 10.2.8. Zendal group
  - 10.2.8.1. Company overview
  - 10.2.8.2. Financial performance
  - 10.2.8.3. Product benchmarking
  - 10.2.8.4. Strategic initiatives
- 10.2.9. Elanco
  - 10.2.9.1. Company overview
  - 10.2.9.2. Financial performance
  - 10.2.9.3. Product benchmarking
  - 10.2.9.4. Strategic initiatives
- 10.2.10. Zoetis Services LLC
  - 10.2.10.1. Company overview
  - 10.2.10.2. Financial performance
  - 10.2.10.3. Product benchmarking
  - 10.2.10.4. Strategic initiatives

Product Code: GVR-4-68040-156-3

List of Tables

1. List of abbreviations
2. North America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
3. North America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
4. North America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
5. North America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
6. North America dog vaccine market, by component, 2018 - 2030 (USD Million)
7. North America dog vaccine market, by region, 2018 - 2030 (USD Million)
8. U.S. dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
9. U.S. dog vaccine market, by disease type, 2018 - 2030 (USD Million)
10. U.S. dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
11. U.S. dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
12. U.S. dog vaccine market, by component, 2018 - 2030 (USD Million)
13. Canada dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
14. Canada dog vaccine market, by disease type, 2018 - 2030 (USD Million)
15. Canada dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
16. Canada dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
17. Canada dog vaccine market, by component, 2018 - 2030 (USD Million)
18. Europe dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
19. Europe dog vaccine market, by disease type, 2018 - 2030 (USD Million)
20. Europe dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
21. Europe dog vaccine market, by duration of immunity type, 2018 - 2030 (USD Million)
22. Europe dog vaccine market, by component type, 2018 - 2030 (USD Million)
23. Europe dog vaccine market, by region, 2018 - 2030 (USD Million)
24. UK dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
25. UK dog vaccine market, by disease type, 2018 - 2030 (USD Million)
26. UK dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
27. UK dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
28. UK dog vaccine market, by component, 2018 - 2030 (USD Million)
29. Germany dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
30. Germany dog vaccine market, by disease type, 2018 - 2030 (USD Million)
31. Germany dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
32. Germany dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
33. Germany Dog Vaccine market, by component, 2018 - 2030 (USD Million)
34. France dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
35. France dog vaccine market, by disease type, 2018 - 2030 (USD Million)
36. France dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
37. France dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
38. Italy dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
39. Italy dog vaccine market, by disease type, 2018 - 2030 (USD Million)
40. Italy dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
41. Italy dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
42. Italy dog vaccine market, by component, 2018 - 2030 (USD Million)
43. Spain dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
44. Spain dog vaccine market, by disease type, 2018 - 2030 (USD Million)
45. Spain dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
46. Spain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
47. Spain dog vaccine market, by component, 2018 - 2030 (USD Million)
48. Sweden dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
49. Sweden dog vaccine market, by disease type, 2018 - 2030 (USD Million)
50. Sweden dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
51. Sweden dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
52. Sweden dog vaccine market, by component, 2018 - 2030 (USD Million)
53. Norway dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
54. Norway dog vaccine market, by disease type, 2018 - 2030 (USD Million)
55. Norway dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
56. Norway pain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
57. Norway dog vaccine market, by component, 2018 - 2030 (USD Million)
58. Denmark dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
59. Denmark dog vaccine market, by disease type, 2018 - 2030 (USD Million)
60. Denmark dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
61. Denmark dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
62. Denmark dog vaccine market, by component, 2018 - 2030 (USD Million)
63. Asia-Pacific dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
64. Asia-Pacific dog vaccine market, by disease type, 2018 - 2030 (USD Million)
65. Asia-Pacific dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
66. Asia-Pacific dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
67. Asia-Pacific dog vaccine market, by component, 2018 - 2030 (USD Million)
68. Asia pacific dog vaccine market, by region, 2018 - 2030 (USD Million)
69. Japan dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
70. Japan dog vaccine market, by disease type, 2018 - 2030 (USD Million)
71. Japan dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
72. Japan dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
73. Japan dog vaccine market, by component, 2018 - 2030 (USD Million)
74. China dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
75. China dog vaccine market, by disease type, 2018 - 2030 (USD Million)
76. China dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
77. China dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
78. China dog vaccine market, by component, 2018 - 2030 (USD Million)
79. India dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
80. India dog vaccine market, by disease type, 2018 - 2030 (USD Million)
81. India dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
82. India dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
83. India dog vaccine market, by component, 2018 - 2030 (USD Million)
84. Australia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
85. Australia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
86. Australia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
87. Australia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
88. Australia dog vaccine market, by component, 2018 - 2030 (USD Million)
89. Thailand dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
90. Thailand dog vaccine market, by disease type, 2018 - 2030 (USD Million)
91. Thailand dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
92. Thailand dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
93. Thailand dog vaccine market, by component, 2018 - 2030 (USD Million)
94. South Korea dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
95. South Korea dog vaccine market, by disease type, 2018 - 2030 (USD Million)
96. South Korea dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
97. South Korea dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
98. South Korea dog vaccine market, by component, 2018 - 2030 (USD Million)
99. Latin America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
100. Latin America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
101. Latin America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
102. Latin America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
103. Latin America dog vaccine market, by component, 2018 - 2030 (USD Million)
104. Latin America Dog Vaccine market, by region, 2018 - 2030 (USD Million)
105. Brazil dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
106. Brazil dog vaccine market, by disease type, 2018 - 2030 (USD Million)
107. Brazil dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
108. Brazil dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
109. Brazil dog vaccine market, by component, 2018 - 2030 (USD Million)
110. Mexico dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
111. Mexico dog vaccine market, by disease type, 2018 - 2030 (USD Million)
112. Mexico dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
113. Mexico dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
114. Mexico dog vaccine market, by component, 2018 - 2030 (USD Million)
115. Argentina dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
116. Argentina dog vaccine market, by disease type, 2018 - 2030 (USD Million)
117. Argentina dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
118. Argentina dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
119. Argentina dog vaccine market, by component, 2018 - 2030 (USD Million)
120. Middle East and Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
121. Middle East and Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
122. Middle East and Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
123. Middle East and Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
124. Middle East and Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
125. Middle East and Africa Dog Vaccine market, by region, 2018 - 2030 (USD Million)
126. South Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
127. South Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
128. South Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
129. South Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
130. South Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
131. Saudi Arabia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
132. Saudi Arabia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
133. Saudi Arabia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
134. Saudi Arabia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
135. Saudi Arabia dog vaccine market, by component, 2018 - 2030 (USD Million)
136. UAE dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
137. UAE dog vaccine market, by disease type, 2018 - 2030 (USD Million)
138. UAE dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
139. UAE dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
140. UAE dog vaccine market, by component, 2018 - 2030 (USD Million)
141. Kuwait dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
142. Kuwait dog vaccine market, by disease type, 2018 - 2030 (USD Million)]
143. Kuwait dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
144. Kuwait dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
145. Kuwait dog vaccine market, by component, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. QFD modeling for market share assessment

6. Market formulation & validation

7. Dog Vaccines: Market outlook

8. Dog Vaccines: Competitive insights

9. Parent market outlook

10. Related/ancillary market outlook

11. Penetration and growth prospect mapping

12. Industry value chain analysis

13. Dog vaccine market driver impact

14. Dog vaccine market restraint impact

15. Dog vaccine market strategic initiatives analysis

16. Dog vaccine market: Vaccine type movement analysis

17. Dog vaccine market: Vaccine type outlook and key takeaways

18. Modified/ attenuated live market estimates and forecasts, 2018 - 2030

19. Inactivated (Killed) market estimates and forecasts, 2018 - 2030

20. Others market estimates and forecasts, 2018 - 2030

21. Dog vaccine market: Disease type movement analysis

22. Dog vaccine market: Disease type outlook and key takeaways

23. Canine distemper market estimates and forecasts, 2018 - 2030

24. Canine infectious respiratory disease complex (CIRDC)market estimates and forecasts, 2018 - 2030

25. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 - 2030

26. Canine Lyme disease market estimates and forecasts, 2018 - 2030

27. Infectious canine hepatitis market estimates and forecasts, 2018 - 2030

28. Canine rabies market estimates and forecasts, 2018 - 2030

29. Other diseases market estimates and forecasts, 2018 - 2030

30. Dog Vaccine market: Route of administration movement analysis

31. Dog Vaccine market: Route of administration outlook and key takeaways

32. Injectable market estimates and forecasts, 2018 - 2030

33. Intranasal market estimates and forecasts, 2018 - 2030

34. Oral market estimates and forecasts, 2018 - 2030

35. Dog Vaccine market: Duration of immunity movement analysis

36. Dog Vaccine market: Duration of immunity outlook and key takeaways

37. 1 year market estimates and forecasts, 2018 - 2030

38. 3-year market estimates and forecasts, 2018 - 2030

39. others market estimates and forecasts, 2018 - 2030

40. Dog Vaccine market: Component movement analysis

41. Dog Vaccine market: Component of immunity outlook and key takeaways

42. Combined vaccines market estimates and forecasts, 2018 - 2030

43. Mono vaccines market estimates and forecasts, 2018 - 2030

44. Global dog vaccine market: Regional movement analysis

45. Global dog vaccine market: Regional outlook and key takeaways

46. North America market estimates and forecasts, 2018 - 2030

47. U.S. market estimates and forecasts, 2018 - 2030

48. Canada market estimates and forecasts, 2018 - 2030

49. Europe market estimates and forecasts, 2018 - 2030

50. UK market estimates and forecasts, 2018 - 2030

51. Germany market estimates and forecasts, 2018 - 2030

52. France market estimates and forecasts, 2018 - 2030

53. Italy market estimates and forecasts, 2018 - 2030

54. Spain market estimates and forecasts, 2018 - 2030

55. Denmark market estimates and forecasts, 2018 - 2030

56. Sweden market estimates and forecasts, 2018 - 2030

57. Norway market estimates and forecasts, 2018 - 2030

58. Asia Pacific market estimates and forecasts, 2018 - 2030

59. Japan market estimates and forecasts, 2018 - 2030

60. China market estimates and forecasts, 2018 - 2030

61. India market estimates and forecasts, 2018 - 2030

62. Australia market estimates and forecasts, 2018 - 2030

63. Thailand market estimates and forecasts, 2018 - 2030

64. South Korea market estimates and forecasts, 2018 - 2030

65. Latin America market estimates and forecasts, 2018 - 2030

66. Brazil market estimates and forecasts, 2018 - 2030

67. Mexico market estimates and forecasts, 2018 - 2030

68. Argentina market estimates and forecasts, 2018 - 2030

69. Middle East and Africa. market estimates and forecasts, 2018 - 2030

70. Saudi Arabia market estimates and forecasts, 2018 - 2030

71. South Africa market estimates and forecasts, 2018 - 2030

72. UAE market estimates and forecasts, 2018 - 2030

73. Kuwait market estimates and forecasts, 2018 - 2030

Dog Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Dog Vaccine Market Growth & Trends:

Dog Vaccine Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Dog Vaccine Market Variables, Trends & Scope

Chapter 4. Dog Vaccine: Vaccine Type Estimates & Trend Analysis

Chapter 5. Dog Vaccine: Disease Type Estimates & Trend Analysis

Chapter 6. Dog Vaccine: Route of Administration Estimates & Trend Analysis

Chapter 7. Dog Vaccine: Duration of Immunity Estimates & Trend Analysis

Chapter 8. Dog Vaccine: Component Estimates & Trend Analysis

Chapter 9. Dog Vaccine Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

List of Tables